$32 million additional capital raised, supported by all major existing investors and new investor Kreos Capital Ongoing Phase 1b trial of CB307 enhanced with additional pembrolizumab combination ...
Crescendo Health Launches to Improve and Accelerate Clinical Trials By Unlocking Patient Health Data
Crescendo Health’s real-world data platform creates partnerships between researchers and patients to gain greater longitudinal insights into health outcomes from clinical research. Company also raises ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results